Framingham Issue 1 2023 - Myeloma Platform

RRMM

Framingham Issue 1 2023

Download issue 1

Share this article with your colleagues

MAT-DK-2200537 (ver.1.0) 02 2023

Also interesting...

RRMM

How to get your head around optimal sequencing in RRMM?

NK Cells, RRMM

Review: NK cell therapy in relapsed refractory multiple myeloma

RRMM

Framingham Issue 2 2023

MRD, NDMM, RRMM

MRD as primary endpoint

MRD, NDMM, RRMM

Minimal Residual Disease (MRD) – Cost vs Benefit